CM
KNSA icon

Caption Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Caption Management’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48.1M Sell
999,400
-491,100
-33% -$21.8M 0.28% 71
2025
Q4 		$61.5M Buy
1,490,500
+987,900
+197% +$39.6M 0.42% 49
2025
Q3 		$19.5M Buy
502,600
+272,600
+119% +$8.86M 0.15% 147
2025
Q2 		$6.36M Buy
230,000
+200,000
+667% +$5.09M 0.07% 331
2025
Q1 		$666K Buy
+30,000
New +$617K 0.01% 1023
2024
Q4 		– Sell
-30,000
Closed -$750K – 1654
2024
Q3 		$750K Buy
+30,000
New +$731K 0.01% 847
2024
Q1 		– Sell
-296,200
Closed -$5.2M – 1452
2023
Q4 		$5.2M Buy
296,200
+216,200
+270% +$3.55M 0.07% 325
2023
Q3 		$1.39M Buy
80,000
+20,000
+33% +$337K 0.02% 680
2023
Q2 		$845K Sell
60,000
-5,000
-8% -$66.9K 0.02% 701
2023
Q1 		$699K Buy
65,000
+30,000
+86% +$395K 0.01% 712
2022
Q4 		$524K Buy
35,000
+5,000
+17% +$72.8K 0.01% 912
2022
Q3 		$386K Sell
30,000
-30,000
-50% -$342K 0.01% 1126
2022
Q2 		$581K Sell
60,000
-45,000
-43% -$420K 0.01% 1039
2022
Q1 		$1.04M Buy
105,000
+30,000
+40% +$318K 0.01% 958
2021
Q4 		$883K Buy
75,000
+45,000
+150% +$553K 0.01% 1088
2021
Q3 		$342K Hold
30,000
– – ﹤0.01% 1269
2021
Q2 		$418K Sell
30,000
-30,000
-50% -$456K 0.01% 1083
2021
Q1 		$1.11M Buy
60,000
+30,000
+100% +$614K 0.02% 662
2020
Q4 		$530K Hold
30,000
– – 0.01% 730
2020
Q3 		$459K Buy
+30,000
New +$563K 0.01% 788

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Caption Management's KNSA Position: Q3 2024 in Review

Caption Management sold out of Kiniksa Pharmaceuticals (KNSA) in Q3 2024, closing a stake of 4,065 shares — an estimated $99K sold.

Caption Management first reported a position in KNSA in Q3 2020 and held it in 9 quarters. The position peaked at $651K in Q1 2022. 176 funds tracked by Wall St. Rank hold KNSA as of Q3 2024.

  • Caption Management reported no remaining Kiniksa Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Caption Management sold 4,065 Kiniksa Pharmaceuticals shares in Q3 2024, an estimated $99K.
  • Caption Management first reported a position in Kiniksa Pharmaceuticals in Q3 2020 and held it in 9 quarters.
  • Caption Management's Kiniksa Pharmaceuticals position peaked at $651K in Q1 2022.
  • 176 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2024.

Based on Caption Management's 13F filing for Q3 2024, filed 14 Nov 2024.